Taiwan Business TOPICS Local pharmaceutical firm Golden Biotechnology Corp. independently developed Antroquinonol
(Hocena®), a novel small-molecule drug, and is now testing its use for treatment of COVID-19. Photo: Golden Biotechnology Corp.
Despite rigorous border control and strict measures, COVID-19 has made its way into Taiwan. Now businesses, researchers, and government are working on innovations that will put Taiwan back in business.
Until recently, Taiwan had a remarkable success record in containing the spread of COVID-19 and maintaining normality for its citizens. While hospitals worldwide had their capacities stretched to their limits, Taiwan reported approximately 1,200 local cases and 11 related deaths in 14 months. However, in May, a few local clusters resulted in a significant spread of the coronavirus around the island.
Covid-19: Learning from the Asian Tigers
May 6, 2021
Some countries in Asia have dealt far better with Covid-19 than those in Europe, often as a result of previous experience with similar viruses in the recent past. What can we learn from them?
“Innovation in healthcare has seen a boost during Covid-19 pandemic. But we need to be careful in our optimism: we need to make sure that the innovations we use are sustainable, and can be used in the long term,” says Tamás Békási, RIS business creation manager, EIT Health InnoStars, a network of best-in-class health innovators backed by the EU.
Breaking ground
Vice President William Lai, front, center, Minister of Transportation and Communications Lin Chia-lung, front second left, Taiwan AI Federated Learning Alliance (TAIFA) chairman Ethan Tu, front second right, and other officials pose for photographers at an event to mark the founding of TAIFA in Taipei yesterday.
Photo: Tu Chien-jung, Taipei Times Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.